PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,278,000 | -0.2% | 42,832 | +9.4% | 0.65% | +3.0% |
Q2 2022 | $2,283,000 | -23.6% | 39,166 | 0.0% | 0.63% | +12.1% |
Q1 2022 | $2,989,000 | +24.7% | 39,166 | -1.7% | 0.56% | +32.4% |
Q4 2021 | $2,397,000 | -24.4% | 39,838 | -29.7% | 0.43% | -6.2% |
Q3 2021 | $3,172,000 | -7.7% | 56,638 | 0.0% | 0.45% | -4.2% |
Q2 2021 | $3,437,000 | -13.4% | 56,638 | 0.0% | 0.47% | -17.0% |
Q1 2021 | $3,970,000 | – | 56,638 | – | 0.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |